Hematology/Oncology Department
Research Studies Open for Enrollment
|
UCSF Benioff Children's Hospital Oakland Hematology/Oncology Department Research Studies Open for Enrollment |
Date: 07/13/2020 |
|---|
| Title | ID/Protocol | NCT/Phase | Sponsor | P.I. | Contact |
| NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE) - PHASE 2 SUBPROTOCOL OF AG-120 (IVOSIDENIB) IN PATIENTS WITH TUMORS HARBORING IDH1 MUTATIONS | APEC1621K | NCT04195555 Phase 2 | Children's Oncology Group (COG) | Carla Golden, MD | Diane Olszewski (510-428-3885 x 3246) |
| A Phase 2 Study of Veliparib (ABT-888, IND # 139199) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma (HGG) without H3 K27M or BRAFV600 Mutations | ACNS1721 | 03581292 Phase 2 | Children's Oncology Group (COG) | Carla Golden, MD | Diane Olszewski (510-428-3885 x 3246) |
| A Randomized Web-based Physical Activity Intervention among Children and Adolescents with Cancer | ALTE1631 | 03223753 Phase 3 | Children's Oncology Group (COG) | Carla Golden, MD | Diane Olszewski (510-428-3885 x 3246) |
| Establishing Continuous Cell Lines and xenografts from Pediatric Cancers for Biological and Pre-Clinical Therapeutic Studies | ABTR04B1 | N/A | Children's Oncology Group (COG) | Carla Golden, MD | Diane Olszewski (510-428-3885 x 3246) |
| Project:EveryChild A Registry, Eligibility Screening, Biology and Outcome Study | APEC14B1 | N/A | Children's Oncology Group (COG) | Carla Golden, MD | Diane Olszewski (510-428-3885 x 3246) |
| Genomic Analysis in Pediatric Malignancies | Genomics | N/A | N/A | Tabitha Cooney, MD | Tabitha Cooney, MD |
| Phase 2 Study of everolimus for recurrent or progression low-grade gliomas in children | PNOC001 | NCT01734512 Phase 2 | Pacific Pediatric Neuro-Oncology Consortium (PNOC) | Caroline Hastings, MD | Caroline Hastings, MD |
| Prospective multi-institutional study to assess the risk of radiation induced vasculopathy and stroke as well as stroke recurrence in children with cancer who received radiation therapy to the neck and/or brain | RadART-Pro | N/A | LaRoche Family | Joseph Torkildson, MD | Joseph Torkildson, MD |
| Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients | ACNS1422 | 02724579 Phase 2 | Children's Oncology Group (COG) | Carla Golden, MD | Diane Olszewski (510-428-3885 x 3246) |
| Clinical/Molecular Risk-Tailored Intensive, Compressed Induction Chemotherapy Followed by Consolidation Randomization To Single-Cycle or 3 Tandem Cycles of Marrow-Ablative Chemo with Hematopoietic Progenitor Cell Rescue | Head-Start-4 | NCT02875314 Phase 4 | Next Consortium, Nationwide Children's | Caroline Hastings, MD | Effie Bourgin |